THRAP3 and ovarian serous cystadenocarcinoma: THRAP3 expression was found to be substantially linked with stage in 7 malignancies, including adrenocortical carcinoma (ACC), breast invasive carcinoma (BRCA), colon adenocarcinoma (COAD), head and neck squamous cell carcinoma (HNSC), KIRC, liver hepatocellular carcinoma (LIHC), and ovarian serous cystadenocarcinoma (OV).